SS 08 - H&N 3: Addressing High-Risk Challenges Head On: Mitigating Toxicity and Reducing Recurrences

Moderator(s)

• 

  Shyam Rao, MD, PhD

  University of California Davis
  Sacramento, CA
• MM

  Mark McDonald, MD

  Winship Cancer Institute of Emory University
  Atlanta, Georgia

Presentations:

• 4:45 PM – 4:55 PM ET

  A Phase II Trial of Camrelizumab in Combination with Concurrent Chemoradiotherapy as First-Line Treatment for Betel Nut-Related Locally Advanced Oral Squamous Cell Carcinoma
  

  Presenter: Feng Liu, MD – Hunan Cancer Hospital
• 4:55 PM – 5:05 PM ET

  Contralateral Neck Recurrence Rates in Head and Neck Carcinomas after Primary Surgery, Bilateral Neck Dissection, a Pathologically Negative Contralateral Neck, and Adjuvant Ipsilateral Neck Radiation
  

  Presenter: Kendall Kiser, MD, MS – Washington University/B-JH/SLCH Consortium
• 5:05 PM – 5:15 PM ET

  Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
  

  Presenter: Nancy Lee, MD, FASTRO – Memorial Sloan Kettering Cancer Center
• 5:15 PM – 5:25 PM ET

  Acupuncture for (Chemo)Radiotherapy - Related Dysphagia in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase 2 Study
  

  Presenter: Pierluigi Bonomo, MD – Azienda Ospedaliera Universitaria Careggi
• 5:25 PM – 5:35 PM ET

  Opioid Therapy vs. Multimodal Analgesia in Head and Neck Cancer (OPTIMAL-HN): Results of a Randomized Clinical Trial
  

  Presenter: Sondos Zayed, MD, MPH, FRCPC – University of Ottawa at The Ottawa Hospital
• 5:35 PM – 5:45 PM ET

  Long Term Effects of Cognitive Behavioral Therapy on Late Toxicities, Depressive and Anxiety Symptoms in Patients with Locoregional Advanced Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: A Ra
  

  Presenter: Feng Liu, MD – Hunan Cancer Hospital
• 5:45 PM – 5:55 PM ET

  Discussant
  

  Discussant: Christina Henson, MD – University of Oklahoma Health Sciences Center